| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Tiwari is Mathematical Statistician, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Ghafoor is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Samuels is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Feuer is Branch Chief, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Dr. Thun is Vice-President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival rates based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and mortality rates are age standardized to the 2000 US standard million population. A total of 1,368,030 new cancer cases and 563,700 deaths are expected in the United States in 2004. Incidence rates stabilized among men from 1995 through 2000 but continued to increase among females by 0.4% per year from 1987 through 2000. Mortality rates have decreased by 1.5% per year since 1992 among men, but have stabilized from 1998 through 2000 among women. Cancer death rates continued to decrease from the three major cancer sites in men (lung and bronchus, colon and rectum, and prostate) and from female breast and colorectal cancers in women. In analyses by race and ethnicity, African-American men and women have 40% and 20% higher death rates from all cancers combined compared with White men and women, respectively. Cancer incidence and mortality rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites. However, these groups generally have higher rates for stomach, liver, and cervical cancers than do Whites. Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites. Progress in reducing the burden from cancer can be accelerated by applying existing cancer control knowledge into practice among all segments of the population.
This article has been cited by other articles:
|
|
 |
|
  S. Shirotake, E. Kikuchi, K. Matsumoto, S. Yazawa, T. Kosaka, A. Miyajima, K. Nakagawa, and M. Oya Role of Pelvic Lymph Node Dissection in Lymph Node-Negative Patients with Invasive Bladder Cancer Jpn. J. Clin. Oncol., March 1, 2010; 40(3): 247 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-L. Tsai, B.-Y. Ho, and T.-M. Pan Red Mold Rice Mitigates Oral Carcinogenesis in 7,12-Dimethyl-1,2-Benz[a]anthracene-induced Oral Carcinogenesis in Hamster Evid. Based Complement. Altern. Med., December 17, 2009; (2009) nep215v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Fowler, G. R. Mundy, S. T. Lwin, C. C. Lynch, and C. M. Edwards A murine model of myeloma that allows genetic manipulation of the host microenvironment Dis. Model. Mech., November 1, 2009; 2(11-12): 604 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. GOERGENS, M. FRERICKS, and C. ESSER The Arylhydrocarbon Receptor Is Only Marginally Involved in the Antileukemic Effects of its Ligand Curcumin Anticancer Res, November 1, 2009; 29(11): 4657 - 4664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. S. Crawford, H. Yang, K. R. Mattaini, and K. W. Hunter The Metastasis Efficiency Modifier Ribosomal RNA Processing 1 Homolog B (RRP1B) Is a Chromatin-associated Factor J. Biol. Chem., October 16, 2009; 284(42): 28660 - 28673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. SKAGIAS, E. POLITI, A. KARAMERIS, D. SAMBAZIOTIS, A. ARCHONDAKIS, A. NTINIS, I. MOREAS, O. VASOU, H. KOUTSELINI, and E. PATSOURIS Survivin Expression as a Strong Indicator of Recurrence in Urothelial Bladder Cancer. Predictive Value of Nuclear versus Cytoplasmic Staining Anticancer Res, October 1, 2009; 29(10): 4163 - 4167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. FABRINI, A. GADDUCCI, F. PERRONE, S. COSIO, C. LALISCIA, F. PASQUALETTI, S. GRESPI, and L. CIONINI Clinical Outcome of Tailored Adjuvant Postoperative Chemoradiotherapy in IB FIGO Stage Cervical Cancer Anticancer Res, October 1, 2009; 29(10): 4205 - 4210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. TAHARA, T. SHIBATA, M. NAKAMURA, H. YAMASHITA, D. YOSHIOKA, I. HIRATA, and T. ARISAWA RANTES Promoter Genotype and Gastric Cancer Risk in a Japanese Population Anticancer Res, October 1, 2009; 29(10): 4265 - 4269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. W. Wertheim, T. W. Yang, T.-c. Pan, A. Ramne, Z. Liu, H. P. Gardner, K. D. Dugan, P. Kristel, B. Kreike, M. J. van de Vijver, et al. The Snf1-related kinase, Hunk, is essential for mammary tumor metastasis PNAS, September 15, 2009; 106(37): 15855 - 15860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Jang, A. Le Maitre, K. Ding, T. Winton, A. Bezjak, L. Seymour, F. A. Shepherd, and N. B. Leighl Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial J. Clin. Oncol., September 10, 2009; 27(26): 4268 - 4273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. SERTZNIG, T. DUNLOP, M. SEIFERT, W. TILGEN, and J. REICHRATH Cross-talk between Vitamin D Receptor (VDR)- and Peroxisome Proliferator-activated Receptor (PPAR)-signaling in Melanoma Cells Anticancer Res, September 1, 2009; 29(9): 3647 - 3658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Dale "Staging the Aging" When Considering Androgen Deprivation Therapy for Older Men With Prostate Cancer J. Clin. Oncol., July 20, 2009; 27(21): 3420 - 3422. [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Azab, F. Azab, S. Blotta, C. M. Pitsillides, B. Thompson, J. M. Runnels, A. M. Roccaro, H. T. Ngo, M. R. Melhem, A. Sacco, et al. RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma Blood, July 16, 2009; 114(3): 619 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Miranda, M. K. Hassumi, M. C.M. Guimaraes, R. T. Simoes, T. G.A. Silva, R. C.P. Lira, A. M. Rocha, C. T. Mendes Jr., E. A. Donadi, C. P. Soares, et al. Galectin-3 Overexpression in Invasive Laryngeal Carcinoma, Assessed by Computer-assisted Analysis J. Histochem. Cytochem., July 1, 2009; 57(7): 665 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Buhmeida, R. Bendardaf, M. Hilska, J. Laine, Y. Collan, M. Laato, K. Syrjanen, and S. Pyrhonen PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma Ann. Onc., July 1, 2009; 20(7): 1230 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. PROSCHEK, A. KURTH, P. PROSCHEK, T. J. VOGL, and M. G. MACK Prospective Pilot-study of Combined Bipolar Radiofrequency Ablation and Application of Bone Cement in Bone Metastases Anticancer Res, July 1, 2009; 29(7): 2787 - 2792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Andrew, R. A. Mason, V. Memoli, and E. J. Duell Arsenic Activates EGFR Pathway Signaling in the Lung Toxicol. Sci., June 1, 2009; 109(2): 350 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. SOORIAKUMARAN, H. M. COLEY, S. B. FOX, P. MACANAS-PIRARD, D. P. LOVELL, A. HENDERSON, C. G. EDEN, P. D. MILLER, S. E.M. LANGLEY, and R. W. LAING A Randomized Controlled Trial Investigating the Effects of Celecoxib in Patients with Localized Prostate Cancer Anticancer Res, May 1, 2009; 29(5): 1483 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Lubbe, D. S. Zuzga, Z. Zhou, W. Fu, J. Pelta-Heller, R. J. Muschel, S. A. Waldman, and G. M. Pitari Guanylyl Cyclase C Prevents Colon Cancer Metastasis by Regulating Tumor Epithelial Cell Matrix Metalloproteinase-9 Cancer Res., April 15, 2009; 69(8): 3529 - 3536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. McFall, J. Ureda, T. L. Byrd, A. Valdes, P. Morales, D. B. Scott, D. Williams, J. Calderon-Mora, M. E. Casillas, and E. C. Y. Chan What is needed for informed decisions about prostate cancer screening: perspectives of African-American and Hispanic men Health Educ. Res., April 1, 2009; 24(2): 280 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Saidak, R. Mentaverri, and E. M. Brown The Role of the Calcium-Sensing Receptor in the Development and Progression of Cancer Endocr. Rev., April 1, 2009; 30(2): 178 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ychou, J.-L. Raoul, J.-Y. Douillard, S. Gourgou-Bourgade, R. Bugat, L. Mineur, F. Viret, Y. Becouarn, O. Bouche, E. Gamelin, et al. A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) Ann. Onc., April 1, 2009; 20(4): 674 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. KIM, K. ZUKOWSKI, and R. F. NOVAK Rapamycin Effects on mTOR Signaling in Benign, Premalignant and Malignant Human Breast Epithelial Cells Anticancer Res, April 1, 2009; 29(4): 1143 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. SOORIAKUMARAN, P. MACANAS-PIRARD, G. BUCCA, A. HENDERSON, S.E.M. LANGLEY, R.W. LAING, C.P. SMITH, E.E. LAING, and H.M. COLEY A Gene Expression Profiling Approach Assessing Celecoxib in a Randomized Controlled Trial in Prostate Cancer Cancer Genomics Proteomics, March 1, 2009; 6(2): 93 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kwon, S. Stephan, A. Mukhopadhyay, M. H. Muders, S. K. Dutta, J. S. Lau, and D. Mukhopadhyay Insulin Receptor Substrate-2 Mediated Insulin-like Growth Factor-I Receptor Overexpression in Pancreatic Adenocarcinoma through Protein Kinase C{delta} Cancer Res., February 15, 2009; 69(4): 1350 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-C. Hsieh, Y.-W. Cheng, C.-J. Lin, M.-C. Chou, C.-Y. Chen, and H. Lee Prognostic Significance of X-ray Cross-complementing Group 1 T-77C Polymorphism in Resected Non-small Cell Lung Cancer Jpn. J. Clin. Oncol., February 1, 2009; 39(2): 81 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Gilbert, C. P. Cannon, P. P. Lin, and V. O. Lewis Soft-tissue Sarcoma J. Am. Acad. Ortho. Surg., January 1, 2009; 17(1): 40 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. BUHMEIDA, M. HILSKA, A. ELZAGHEID, M. LAATO, Y. COLLAN, K. SYRJANEN, and S. PYRHONEN DNA Image Cytometry Predicts Disease Outcome in Stage II Colorectal Carcinoma Anticancer Res, January 1, 2009; 29(1): 99 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Blum, T. Koyama, A. E. M'Koma, J. M. Iturregui, M. Martinez-Ferrer, C. Uwamariya, J. A. Smith Jr., P. E. Clark, and N. A. Bhowmick Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy Clin. Cancer Res., December 1, 2008; 14(23): 7790 - 7797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Qin, H.-J. Kim, J.-Y. Kim, E. M. Hurt, G. J. Klarmann, B. T. Kawasaki, M. A. Duhagon Serrat, and W. L. Farrar Activation of Signal Transducer and Activator of Transcription 3 through a Phosphomimetic Serine 727 Promotes Prostate Tumorigenesis Independent of Tyrosine 705 Phosphorylation Cancer Res., October 1, 2008; 68(19): 7736 - 7741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Bailey, B. J. Swanson, T. Hamada, J. P. Eggers, P. K. Singh, T. Caffery, M. M. Ouellette, and M. A. Hollingsworth Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer Clin. Cancer Res., October 1, 2008; 14(19): 5995 - 6004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Knab, J. K. Salama, A. Solanki, K. M. Stenson, E. E. Cohen, M. E. Witt, D. J. Haraf, and E. E. Vokes Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma Ann. Onc., September 1, 2008; 19(9): 1650 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eiblmaier, L. A. Meyer, M. A. Watson, P. M. Fracasso, L. J. Pike, and C. J. Anderson Correlating EGFR Expression with Receptor-Binding Properties and Internalization of 64Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines J. Nucl. Med., September 1, 2008; 49(9): 1472 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A Gilchrest Sun exposure and vitamin D sufficiency Am. J. Clinical Nutrition, August 1, 2008; 88(2): 570S - 577S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Pitari, J. E. Lin, F. J. Shah, W. J. Lubbe, D. S. Zuzga, P. Li, S. Schulz, and S. A. Waldman Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells Carcinogenesis, August 1, 2008; 29(8): 1601 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Masciullo, E. Berardengo, A. Boglione, A. Sgambato, A. Bernardi, M. Forni, A. Linari, L. Cito, G. Scambia, A. Comandone, et al. The Retinoblastoma Family Member pRb2/p130 Is an Independent Predictor of Survival in Human Soft Tissue Sarcomas Clin. Cancer Res., August 1, 2008; 14(15): 4775 - 4779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lu, H. Xiao, H. You, Y. Lin, H. Jin, B. Snagaski, and C. S. Yang Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin Clin. Cancer Res., August 1, 2008; 14(15): 4981 - 4988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Summers, L. R. Handwerker, P. J. Pickhardt, R. L. Van Uitert, K. K. Deshpande, S. Yeshwant, J. Yao, and M. Franaszek Performance of a Previously Validated CT Colonography Computer-Aided Detection System in a New Patient Population Am. J. Roentgenol., July 1, 2008; 191(1): 168 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Psyrri, P. Kountourakis, A. Scorilas, S. Markakis, R. Camp, D. Kowalski, E. P. Diamandis, and M. A. Dimopoulos Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression Ann. Onc., July 1, 2008; 19(7): 1271 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. R. Placencio, A.-R. Sharif-Afshar, X. Li, H. Huang, C. Uwamariya, E. G. Neilson, M. M. Shen, R. J. Matusik, S. W. Hayward, and N. A. Bhowmick Stromal Transforming Growth Factor-{beta} Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt Activity Cancer Res., June 15, 2008; 68(12): 4709 - 4718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ralhan, L. V. DeSouza, A. Matta, S. Chandra Tripathi, S. Ghanny, S. Datta Gupta, S. Bahadur, and K. W. M. Siu Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry Mol. Cell. Proteomics, June 1, 2008; 7(6): 1162 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kitajima, K. Murakami, E. Yamasaki, I. Fukasawa, N. Inaba, Y. Kaji, and K. Sugimura Accuracy of 18F-FDG PET/CT in Detecting Pelvic and Paraaortic Lymph Node Metastasis in Patients with Endometrial Cancer Am. J. Roentgenol., June 1, 2008; 190(6): 1652 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vicent, D. Luis-Ravelo, I. Anton, I. Garcia-Tunon, F. Borras-Cuesta, J. Dotor, J. De Las Rivas, and F. Lecanda A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism Cancer Res., April 1, 2008; 68(7): 2275 - 2285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Cotton, M. K. O'Bryan, and B. T. Hinton Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction Endocr. Rev., April 1, 2008; 29(2): 193 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Takei, Y. Saga, H. Mizukami, T. Takayama, M. Ohwada, K. Ozawa, and M. Suzuki Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice Mol. Cancer Ther., March 1, 2008; 7(3): 704 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Fletcher, B. Djulbegovic, H. P. Soares, B. A. Siegel, V. J. Lowe, G. H. Lyman, R. E. Coleman, R. Wahl, J. C. Paschold, N. Avril, et al. Recommendations on the Use of 18F-FDG PET in Oncology J. Nucl. Med., March 1, 2008; 49(3): 480 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Steinert, M. Hantschick, M. Vieth, I. Gastinger, F. Kuhnel, H. Lippert, and M. A. Reymond Influence of Subclinical Tumor Spreading on Survival After Curative Surgery for Colorectal Cancer Arch Surg, February 1, 2008; 143(2): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Dubinsky, C. Cuevas, M. K. Dighe, O. Kolokythas, and J. H. Hwang High-Intensity Focused Ultrasound: Current Potential and Oncologic Applications Am. J. Roentgenol., January 1, 2008; 190(1): 191 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Pharo Optimizing Living With Cancer Pain J Am Osteopath Assoc, December 1, 2007; 107(suppl_7): ES1 - ES2. [Full Text] [PDF]
|
|
|
|
|
|
D. -W. Kim, S. -Y. Kim, H. -K. Kim, S. -W. Kim, S. W. Shin, J. S. Kim, K. Park, M. Y. Lee, and D. S. Heo Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Ann. Onc., December 1, 2007; 18(12): 2009 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gallagher, M. Capanu, G. Raggio, and N. Kemeny Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis Ann. Onc., December 1, 2007; 18(12): 1995 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Pharo and L. Zhou Controlling Cancer Pain With Pharmacotherapy J Am Osteopath Assoc, December 1, 2007; 107(suppl_7): ES22 - ES32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Li, J. E. Lin, I. Chervoneva, S. Schulz, S. A. Waldman, and G. M. Pitari Homeostatic Control of the Crypt-Villus Axis by the Bacterial Enterotoxin Receptor Guanylyl Cyclase C Restricts the Proliferating Compartment in Intestine Am. J. Pathol., December 1, 2007; 171(6): 1847 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Boller and H. Nelson Colon and Rectal Cancer: Laparoscopic or Open? Clin. Cancer Res., November 15, 2007; 13(22): 6894s - 6896s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Monin, M. Monchi, M. E.W. Kirsch, H. Petit-Eisenmann, S. Baleynaud, C. Chauvel, D. Metz, C. Adams, J.-P. Quere, P. Gueret, et al. Low-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival Eur. Heart J., November 1, 2007; 28(21): 2620 - 2626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, H. G. Vikis, Y. Yi, M. Futamura, Y. Wang, and M. You Degradation of Lung Adenoma Susceptibility 1, a Major Candidate Mouse Lung Tumor Modifier, Is Required for Cell Cycle Progression Cancer Res., November 1, 2007; 67(21): 10207 - 10213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Kulasingam and E. P. Diamandis Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines: A Mine for Biomarkers and Therapeutic Targets Mol. Cell. Proteomics, November 1, 2007; 6(11): 1997 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. N. Kolar, R. Barhoumi, E. S. Callaway, Y.-Y. Fan, N. Wang, J. R. Lupton, and R. S. Chapkin Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca2+ accumulation in colonocytes Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G935 - G943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oudard, E. Banu, F. Scotte, A. Banu, J. Medioni, P. Beuzeboc, F. Joly, J.-M. Ferrero, F. Goldwasser, and J.-M. Andrieu Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients Ann. Onc., November 1, 2007; 18(11): 1828 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mueller, F. A. Goumas, M. Affeldt, S. Sandtner, U. M. Gehling, S. Brilloff, J. Walter, N. Karnatz, K. Lamszus, X. Rogiers, et al. Stromal Fibroblasts in Colorectal Liver Metastases Originate From Resident Fibroblasts and Generate an Inflammatory Microenvironment Am. J. Pathol., November 1, 2007; 171(5): 1608 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lyshchik, S. B. Hobbs, A. C. Fleischer, D. Khabele, D.-S. Son, J. C. Gore, and R. R. Price Ovarian Volume Measurements in Mice With High-Resolution Ultrasonography J. Ultrasound Med., October 1, 2007; 26(10): 1419 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lapointe, C. Li, C. P. Giacomini, K. Salari, S. Huang, P. Wang, M. Ferrari, T. Hernandez-Boussard, J. D. Brooks, and J. R. Pollack Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis Cancer Res., September 15, 2007; 67(18): 8504 - 8510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, J. Huang, N. Yang, J. Greshock, S. Liang, K. Hasegawa, A. Giannakakis, N. Poulos, A. O'Brien-Jenkins, D. Katsaros, et al. Integrative Genomic Analysis of Phosphatidylinositol 3'-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer Clin. Cancer Res., September 15, 2007; 13(18): 5314 - 5321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Steger, T. Walles, T. Walker, and G. Friedel Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax Eur. Respir. J., September 1, 2007; 30(3): 598 - 599. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Klotz Point: Active Surveillance for Favorable Risk Prostate Cancer J Natl Compr Canc Netw, August 1, 2007; 5(7): 693 - 698. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Rago, F. Santini, M. Scutari, A. Pinchera, and P. Vitti Elastography: New Developments in Ultrasound for Predicting Malignancy in Thyroid Nodules J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2917 - 2922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Mosley, J. T. Poirier, D. D. Seachrist, M. D. Landis, and R. A. Keri Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer Mol. Cancer Ther., August 1, 2007; 6(8): 2188 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A Kuehle, J. Langhorst, S. C Ladd, T. Zoepf, M. Nuefer, F. Grabellus, J. Barkhausen, G. Gerken, and T. C Lauenstein Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population Gut, August 1, 2007; 56(8): 1079 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Erythematous Papules and Plaques Involving the Groin and Scrotum Diagnosis Arch Dermatol, August 1, 2007; 143(8): 1067 - 1072. [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhao, Y. Xiao, P. Elson, H. Tan, S. J. Plummer, M. Berk, P. P. Aung, I. C. Lavery, J. P. Achkar, L. Li, et al. Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer J. Clin. Oncol., July 1, 2007; 25(19): 2696 - 2701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Caron, G. Choquet-Kastylevsky, and R. Joubert-Caron Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery Mol. Cell. Proteomics, July 1, 2007; 6(7): 1115 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.A. Lane, G.Y.H. Lip, and D.G. Beevers Ethnic differences in cancer incidence and mortality: the Birmingham Factory Screening Project QJM, July 1, 2007; 100(7): 423 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lamy, S. Roussi, M. Chaabi, F. Gosse, N. Schall, A. Lobstein, and F. Raul Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis Carcinogenesis, July 1, 2007; 28(7): 1575 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kademani Oral Cancer Mayo Clin. Proc., July 1, 2007; 82(7): 878 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Veit-Haibach, G Antoch, T Beyer, H Stergar, R Schleucher, E A M Hauth, and A Bockisch FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy Br. J. Radiol., July 1, 2007; 80(955): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhu, G. Shi, C. Max. Schmidt, R. H. Hruban, and S. F. Konieczny Acinar Cells Contribute to the Molecular Heterogeneity of Pancreatic Intraepithelial Neoplasia Am. J. Pathol., July 1, 2007; 171(1): 263 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kiziltepe, T. Hideshima, L. Catley, N. Raje, H. Yasui, N. Shiraishi, Y. Okawa, H. Ikeda, S. Vallet, S. Pozzi, et al. 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells Mol. Cancer Ther., June 1, 2007; 6(6): 1718 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-C Eymard, F Priou, A Zannetti, A Ravaud, D Lepille, P Kerbrat, P Gomez, B Paule, D Genet, P Herait, et al. Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer Ann. Onc., June 1, 2007; 18(6): 1064 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tooker, W.-C. Yen, S.-C. Ng, A. Negro-Vilar, and T. W. Hermann Bexarotene (LGD1069, Targretin), a Selective Retinoid X Receptor Agonist, Prevents and Reverses Gemcitabine Resistance in NSCLC Cells by Modulating Gene Amplification Cancer Res., May 1, 2007; 67(9): 4425 - 4433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Welm, J. B. Sneddon, C. Taylor, D. S. A. Nuyten, M. J. van de Vijver, B. H. Hasegawa, and J. M. Bishop The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans PNAS, May 1, 2007; 104(18): 7570 - 7575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Giantonio, P. J. Catalano, N. J. Meropol, P. J. O'Dwyer, E. P. Mitchell, S. R. Alberts, M. A. Schwartz, and A. B. Benson III Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 J. Clin. Oncol., April 20, 2007; 25(12): 1539 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Gatzemeier, A. Pluzanska, A. Szczesna, E. Kaukel, J. Roubec, F. De Rosa, J. Milanowski, H. Karnicka-Mlodkowski, M. Pesek, P. Serwatowski, et al. Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non-Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial J. Clin. Oncol., April 20, 2007; 25(12): 1545 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pepe, B. Hasan, T. L. Winton, L. Seymour, B. Graham, R. B. Livingston, D. H. Johnson, J. R. Rigas, K. Ding, and F. A. Shepherd Adjuvant Vinorelbine and Cisplatin in Elderly Patients: National Cancer Institute of Canada and Intergroup Study JBR.10 J. Clin. Oncol., April 20, 2007; 25(12): 1553 - 1561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Psyrri, P Kountourakis, Z Yu, C Papadimitriou, S Markakis, R. Camp, T Economopoulos, and M. Dimopoulos Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets Ann. Onc., April 1, 2007; 18(4): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. del Carmen, E. F. Halpern, D. B. Kopans, B. Moy, R. H. Moore, P. E. Goss, and K. S. Hughes Mammographic Breast Density and Race Am. J. Roentgenol., April 1, 2007; 188(4): 1147 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Shor, E. A. Keschman, F. Y. Lee, C. Muro-Cacho, G. D. Letson, J. C. Trent, W. J. Pledger, and R. Jove Dasatinib Inhibits Migration and Invasion in Diverse Human Sarcoma Cell Lines and Induces Apoptosis in Bone Sarcoma Cells Dependent on Src Kinase for Survival Cancer Res., March 15, 2007; 67(6): 2800 - 2808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Menon, D. R. Soto-Pantoja, M. F. Callahan, J. M. Cline, C. M. Ferrario, E. A. Tallant, and P. E. Gallagher Angiotensin-(1-7) Inhibits Growth of Human Lung Adenocarcinoma Xenografts in Nude Mice through a Reduction in Cyclooxygenase-2 Cancer Res., March 15, 2007; 67(6): 2809 - 2815. [Abstract] [Full Text] [PDF]
|
|
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
